Head to Head Survey: Sharps Technology (STSS) and The Competition

Sharps Technology (NASDAQ:STSS) is one of 233 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its rivals? We will compare Sharps Technology to related businesses based on the strength of its dividends, profitability, analyst recommendations, institutional ownership, valuation, earnings and risk.

Valuation & Earnings

This table compares Sharps Technology and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sharps Technology	N/A	-$9.84 million	-0.40
Sharps Technology Competitors	$1.03 billion	$3.52 million	-4,660.61

Sharps Technology’s rivals have higher revenue and earnings than Sharps Technology. Sharps Technology is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Sharps Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-102.25%	-72.97%
Sharps Technology Competitors	-663.01%	-133.84%	-28.41%

Risk and Volatility

Sharps Technology has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Comparatively, Sharps Technology’s rivals have a beta of 0.58, meaning that their average stock price is 42% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Sharps Technology and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	0	0	0	0	N/A
Sharps Technology Competitors	1681	4470	8647	233	2.49

As a group, “Surgical & medical instruments” companies have a potential upside of 29.74%. Given Sharps Technology’s rivals higher probable upside, analysts clearly believe Sharps Technology has less favorable growth aspects than its rivals.

Insider and Institutional Ownership

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 48.3% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 14.1% of Sharps Technology shares are held by insiders. Comparatively, 15.2% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Sharps Technology rivals beat Sharps Technology on 6 of the 10 factors compared.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.